Explore Products

My Quote Request

No products added yet

6505-01-528-6335

20 Products

NDC00173-0434-00

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505015286335

NSN

6505-01-528-6335

View More Info

NDC00173-0434-00

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505015286335

NSN

6505-01-528-6335

MFG

GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
ADMINISTRATION: INTRAVENOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 081206
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME F/INJ 1GM ADD-VANTAGE VI TRAY OF 25S
III SUPPLEMENTARY FEATURES: ADD-VANTAGE VIALS TO BE USED BY ABBOTT ADD-VANTAGE DILUENT CONTAINERS ONLY
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: STORE IN A DRY STATE, BETWEEN 15 AND 30 DEG. C; PROTECT FROM LIGHT; TO TREAT OR PREVENT INFECTIONS THAT ARE PROVEN OR STRONGLY SUSPECTED TO BE CAUSED BY BACTERIA; TRAY OF 25S
TOTAL PRIMARY CONTAINER QUANTITY: 25

FORTAZ

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505015286335

NSN

6505-01-528-6335

View More Info

FORTAZ

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505015286335

NSN

6505-01-528-6335

MFG

GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
ADMINISTRATION: INTRAVENOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 081206
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME F/INJ 1GM ADD-VANTAGE VI TRAY OF 25S
III SUPPLEMENTARY FEATURES: ADD-VANTAGE VIALS TO BE USED BY ABBOTT ADD-VANTAGE DILUENT CONTAINERS ONLY
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 GRAMS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: STORE IN A DRY STATE, BETWEEN 15 AND 30 DEG. C; PROTECT FROM LIGHT; TO TREAT OR PREVENT INFECTIONS THAT ARE PROVEN OR STRONGLY SUSPECTED TO BE CAUSED BY BACTERIA; TRAY OF 25S
TOTAL PRIMARY CONTAINER QUANTITY: 25

05-0144

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505015286349

NSN

6505-01-528-6349

View More Info

05-0144

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505015286349

NSN

6505-01-528-6349

MFG

DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
ADMINISTRATION: INTRAVENOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 081206
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME F/INJ 2GM ADD-VANTAGE VIAL, 10'S
III SUPPLEMENTARY FEATURES: ADDVANTAGE VIALS TO BE USED WITH ADDVANTAGE DILUENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 18.000 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: STORE IN A DRY STATE, BETWEEN 15 AND 30 DEG. C; PROTECT FROM LIGHT; FOR IV USE; TO TREAT OR PREVENT INFECTIONS THAT ARE PROVEN OR STRONGLY SUSPECTED TO BE CAUSED BY BACTERIA; TRAY OF 10S
TOTAL PRIMARY CONTAINER QUANTITY: 10

FORTAZ

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505015286349

NSN

6505-01-528-6349

View More Info

FORTAZ

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505015286349

NSN

6505-01-528-6349

MFG

GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
ADMINISTRATION: INTRAVENOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 081206
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME F/INJ 2GM ADD-VANTAGE VIAL, 10'S
III SUPPLEMENTARY FEATURES: ADDVANTAGE VIALS TO BE USED WITH ADDVANTAGE DILUENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 18.000 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: STORE IN A DRY STATE, BETWEEN 15 AND 30 DEG. C; PROTECT FROM LIGHT; FOR IV USE; TO TREAT OR PREVENT INFECTIONS THAT ARE PROVEN OR STRONGLY SUSPECTED TO BE CAUSED BY BACTERIA; TRAY OF 10S
TOTAL PRIMARY CONTAINER QUANTITY: 10

NDC00173-0435-00

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505015286349

NSN

6505-01-528-6349

View More Info

NDC00173-0435-00

CEFTAZIDIME FOR INJECTION,USP

NSN, MFG P/N

6505015286349

NSN

6505-01-528-6349

MFG

GLAXOSMITHKLINE HOLDINGS AMERICAS INC. DIV SMITHKLINE BEECHAM CORPORATION

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT
ADMINISTRATION: INTRAVENOUS
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 081206
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CEFTAZIDIME F/INJ 2GM ADD-VANTAGE VIAL, 10'S
III SUPPLEMENTARY FEATURES: ADDVANTAGE VIALS TO BE USED WITH ADDVANTAGE DILUENT
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 18.000 MILLILITERS AFTER RECONSTITUTION
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: STORE IN A DRY STATE, BETWEEN 15 AND 30 DEG. C; PROTECT FROM LIGHT; FOR IV USE; TO TREAT OR PREVENT INFECTIONS THAT ARE PROVEN OR STRONGLY SUSPECTED TO BE CAUSED BY BACTERIA; TRAY OF 10S
TOTAL PRIMARY CONTAINER QUANTITY: 10

05-0486

TENOFOVIR DISPROXIL

NSN, MFG P/N

6505015290079

NSN

6505-01-529-0079

View More Info

05-0486

TENOFOVIR DISPROXIL

NSN, MFG P/N

6505015290079

NSN

6505-01-529-0079

MFG

DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: TENOFOVIR DISPROXIL FUMARATE TABLETS 300MG 30S
SPECIAL FEATURES: 300MG TENOFOVIR DISPROXIL FUMERATE, 30 TABLETS PER BOTTLE, VIREAD IS INDICATED IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS FOR THE TREATMENT OF HIV-1 INFECTION IN ADULTS

NDC61958-0401-01

TENOFOVIR DISPROXIL

NSN, MFG P/N

6505015290079

NSN

6505-01-529-0079

View More Info

NDC61958-0401-01

TENOFOVIR DISPROXIL

NSN, MFG P/N

6505015290079

NSN

6505-01-529-0079

MFG

GILEAD SCIENCES INC.

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: TENOFOVIR DISPROXIL FUMARATE TABLETS 300MG 30S
SPECIAL FEATURES: 300MG TENOFOVIR DISPROXIL FUMERATE, 30 TABLETS PER BOTTLE, VIREAD IS INDICATED IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS FOR THE TREATMENT OF HIV-1 INFECTION IN ADULTS

VIREAD

TENOFOVIR DISPROXIL

NSN, MFG P/N

6505015290079

NSN

6505-01-529-0079

View More Info

VIREAD

TENOFOVIR DISPROXIL

NSN, MFG P/N

6505015290079

NSN

6505-01-529-0079

MFG

GILEAD SCIENCES INC.

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: TENOFOVIR DISPROXIL FUMARATE TABLETS 300MG 30S
SPECIAL FEATURES: 300MG TENOFOVIR DISPROXIL FUMERATE, 30 TABLETS PER BOTTLE, VIREAD IS INDICATED IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS FOR THE TREATMENT OF HIV-1 INFECTION IN ADULTS

05-0484

ZINC SULFATE,COPPER

NSN, MFG P/N

6505015290086

NSN

6505-01-529-0086

View More Info

05-0484

ZINC SULFATE,COPPER

NSN, MFG P/N

6505015290086

NSN

6505-01-529-0086

MFG

DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: ZINC SULFATE COPPER SULFATE MANGANESE SULFATE AND CHROMIUM CHLORIDE CONCENTRATE FOR INJECTION 10 MCG/ML 1 ML SINGLE DOSE VIAL 25S
SPECIAL FEATURES: ACTIVE MEDICANT MEDICINAL STRENGTH: 5MG ZINC SULFATE, 1MG COPPER SULFATE, 0.5MG MANGANESE SULFATE, 10MCG CHROMIUM CHLORIDE; IV ADMINISTRATION; 1ML SINGLE DOSE VIAL, 25S

NDC00517-7201-25

ZINC SULFATE,COPPER

NSN, MFG P/N

6505015290086

NSN

6505-01-529-0086

View More Info

NDC00517-7201-25

ZINC SULFATE,COPPER

NSN, MFG P/N

6505015290086

NSN

6505-01-529-0086

MFG

LUITPOLD PHARMACEUTICALS INC OSTEOHEALTH COMPANY OSTEOHEALTH DIV

Description

III PART NAME ASSIGNED BY CONTROLLING AGENCY: ZINC SULFATE COPPER SULFATE MANGANESE SULFATE AND CHROMIUM CHLORIDE CONCENTRATE FOR INJECTION 10 MCG/ML 1 ML SINGLE DOSE VIAL 25S
SPECIAL FEATURES: ACTIVE MEDICANT MEDICINAL STRENGTH: 5MG ZINC SULFATE, 1MG COPPER SULFATE, 0.5MG MANGANESE SULFATE, 10MCG CHROMIUM CHLORIDE; IV ADMINISTRATION; 1ML SINGLE DOSE VIAL, 25S

ISOGEL SH 1PCT

SODIUM HYALURONATE INJECTION

NSN, MFG P/N

6505015294324

NSN

6505-01-529-4324

View More Info

ISOGEL SH 1PCT

SODIUM HYALURONATE INJECTION

NSN, MFG P/N

6505015294324

NSN

6505-01-529-4324

MFG

EYEKON MEDICAL INC .

Description

FEATURES PROVIDED: STERILE
SPECIAL FEATURES: SUPPLIED IN 27 GAUGE CANNULA GLASS SYRINGE; STORAGE TEMPERATURE 4 TO 8 DEG. C; USED DURING INTRACULAR SURGERY TO PROTECT INTRACULAR TISSUE, CREATE AND MAINTAIN SPACE AND TO MANIPULATE TISSUE

05-0495

LUBRICANT,SURGICAL

NSN, MFG P/N

6505015295030

NSN

6505-01-529-5030

View More Info

05-0495

LUBRICANT,SURGICAL

NSN, MFG P/N

6505015295030

NSN

6505-01-529-5030

MFG

DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA

Description

FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LUBRICANT SURGICAL STERILE 1/2 OZ. PACKET
III SUPPLEMENTARY FEATURES: FOR ASSAULT MEDICAL KT
PRIMARY CONTAINER CONTENT QUANTITY: 0.500 OUNCES
PRIMARY CONTAINER TYPE: PACKET

6505NCM050668

LUBRICANT,SURGICAL

NSN, MFG P/N

6505015295030

NSN

6505-01-529-5030

View More Info

6505NCM050668

LUBRICANT,SURGICAL

NSN, MFG P/N

6505015295030

NSN

6505-01-529-5030

MFG

DEFENSE MEDICAL STANDARDIZATION BOARD

Description

FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LUBRICANT SURGICAL STERILE 1/2 OZ. PACKET
III SUPPLEMENTARY FEATURES: FOR ASSAULT MEDICAL KT
PRIMARY CONTAINER CONTENT QUANTITY: 0.500 OUNCES
PRIMARY CONTAINER TYPE: PACKET

NAR-SUR

LUBRICANT,SURGICAL

NSN, MFG P/N

6505015295030

NSN

6505-01-529-5030

View More Info

NAR-SUR

LUBRICANT,SURGICAL

NSN, MFG P/N

6505015295030

NSN

6505-01-529-5030

MFG

NORTH AMERICAN RESCUE LLC

Description

FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LUBRICANT SURGICAL STERILE 1/2 OZ. PACKET
III SUPPLEMENTARY FEATURES: FOR ASSAULT MEDICAL KT
PRIMARY CONTAINER CONTENT QUANTITY: 0.500 OUNCES
PRIMARY CONTAINER TYPE: PACKET

ZZ-0037

LUBRICANT,SURGICAL

NSN, MFG P/N

6505015295030

NSN

6505-01-529-5030

View More Info

ZZ-0037

LUBRICANT,SURGICAL

NSN, MFG P/N

6505015295030

NSN

6505-01-529-5030

MFG

NORTH AMERICAN RESCUE LLC

Description

FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LUBRICANT SURGICAL STERILE 1/2 OZ. PACKET
III SUPPLEMENTARY FEATURES: FOR ASSAULT MEDICAL KT
PRIMARY CONTAINER CONTENT QUANTITY: 0.500 OUNCES
PRIMARY CONTAINER TYPE: PACKET

05-0292

CHLORHEXIDINE GLUCO

NSN, MFG P/N

6505015295284

NSN

6505-01-529-5284

View More Info

05-0292

CHLORHEXIDINE GLUCO

NSN, MFG P/N

6505015295284

NSN

6505-01-529-5284

MFG

DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA

Description

III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 520404
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORHEXIDINE GLUCONATE ORAL RINSE PERIOGARD 0.12% 16 OZ
SPECIAL FEATURES: ANTIMICROBIAL 0.12% (1.2 MG/ML) 16 FL. OZ CHLORHEXIDINE GLUCONATE; FOR TREATING GINGIVITIS; MINT FLAVORED; WITH DOSE CAP

506-9175

CHLORHEXIDINE GLUCO

NSN, MFG P/N

6505015295284

NSN

6505-01-529-5284

View More Info

506-9175

CHLORHEXIDINE GLUCO

NSN, MFG P/N

6505015295284

NSN

6505-01-529-5284

MFG

HENRY SCHEIN INC. DIV SPECIAL MARKETS / FEDERAL SALES

Description

III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 520404
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORHEXIDINE GLUCONATE ORAL RINSE PERIOGARD 0.12% 16 OZ
SPECIAL FEATURES: ANTIMICROBIAL 0.12% (1.2 MG/ML) 16 FL. OZ CHLORHEXIDINE GLUCONATE; FOR TREATING GINGIVITIS; MINT FLAVORED; WITH DOSE CAP

NDC00126-0271-16

CHLORHEXIDINE GLUCO

NSN, MFG P/N

6505015295284

NSN

6505-01-529-5284

View More Info

NDC00126-0271-16

CHLORHEXIDINE GLUCO

NSN, MFG P/N

6505015295284

NSN

6505-01-529-5284

MFG

AMERISOURCE BERGEN CORPORATION DIV EDEN PRAIRIE

Description

III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 520404
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORHEXIDINE GLUCONATE ORAL RINSE PERIOGARD 0.12% 16 OZ
SPECIAL FEATURES: ANTIMICROBIAL 0.12% (1.2 MG/ML) 16 FL. OZ CHLORHEXIDINE GLUCONATE; FOR TREATING GINGIVITIS; MINT FLAVORED; WITH DOSE CAP

PERIOGARD

CHLORHEXIDINE GLUCO

NSN, MFG P/N

6505015295284

NSN

6505-01-529-5284

View More Info

PERIOGARD

CHLORHEXIDINE GLUCO

NSN, MFG P/N

6505015295284

NSN

6505-01-529-5284

MFG

HENRY SCHEIN INC. DIV SPECIAL MARKETS / FEDERAL SALES

Description

III AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 520404
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CHLORHEXIDINE GLUCONATE ORAL RINSE PERIOGARD 0.12% 16 OZ
SPECIAL FEATURES: ANTIMICROBIAL 0.12% (1.2 MG/ML) 16 FL. OZ CHLORHEXIDINE GLUCONATE; FOR TREATING GINGIVITIS; MINT FLAVORED; WITH DOSE CAP

05-0489

MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION,USP

NSN, MFG P/N

6505015295618

NSN

6505-01-529-5618

View More Info

05-0489

MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION,USP

NSN, MFG P/N

6505015295618

NSN

6505-01-529-5618

MFG

DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA

Description

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 150.000 MILLIGRAMS MEDROXYPROGESTERONE ACETATE PER MILLILITER
ADMINISTRATION: INTRAMUSCULAR
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER: 683200
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: MEDROXYPROGESTERONE ACETATE INJECTABLE SUSPENSION USP 150MG/ML PREFILLED 1ML SYRINGE
PHARMACEUTICAL VEHICLE TYPE: AQUEOUS
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: PREFILLED SYRINGE
SPECIAL FEATURES: PREFILLED SYRINGES ARE AVAILABLE WITH 22 GAUGE X 1 1/2 BD SAFETY GLIDE NEEDLES; STORE AT CONTROLLED ROOM TEMP 20 TO 25 DEGREE C